Stockreport

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial [Financial Post (Toronto, Ontario, Canada)]

XORTX Therapeutics Inc.  (XRTX) 
PDF the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to tre [Read more]